Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Poult Sci ; 99(2): 744-751, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-32029159

RESUMO

Lycium barbarum polysaccharides (LBP) are considered to be the major bioactive components of L. barbarum and have been widely used as a well-known traditional Chinese medicine and functional food because of their various biological activities. However, no published research has investigated the use of LBP as a feed additive in broilers. The objective of this study was to evaluate the effects of dietary LBP supplementation on the growth performance, digestive enzyme activities, antioxidant status, and immunity of broiler chickens. A total of 256 one-day-old Arbor Acres male broiler chicks were randomly allotted into 4 groups, with 8 replicates of 8 birds each, and were fed a corn-soybean meal-type basal diet supplemented without (control group) or with 1,000, 2,000, or 4,000 mg/kg LBP for 6 wk. The results showed that compared with the control diet, a significant increase in ADG (P < 0.05) during the grower and overall periods was observed in chickens fed the basal diet supplemented with 2,000 mg/kg LBP, whereas supplementation with 1,000 or 2,000 mg/kg LBP decreased feed-to-gain ratio (P < 0.05) during the starter period. The inclusion of LBP in the broiler diets increased overall amylase, lipase, and protease activities (P < 0.05). Supplementation with increasing levels of dietary LBP increased the activities of superoxide dismutase and glutathione peroxidase but decreased malondialdehyde content in the serum and liver (P < 0.05). Broilers fed with LBP-containing diets exhibited higher serum IgG and IgA concentrations (P < 0.05) than the broilers fed with the control diet. Serum tumor necrosis factor α and IL-4 concentrations were significantly elevated in the group fed 2,000 mg/kg LBP compared with the control group (P < 0.05). Broilers fed diets supplemented with LBP showed linear (P < 0.05) and quadratic (P < 0.05) increases in serum IL-6 and interferon gamma concentrations. The results indicated that dietary LBP supplementation can improve growth performance, digestive enzyme activities, antioxidant capacity, and immune function of broilers. In conclusion, LBP may be used as a promising feed additive for broilers, and a supplementation level of 2,000 mg/kg LBP in the broiler diet is recommended.


Assuntos
Antioxidantes/metabolismo , Galinhas , Carboidratos da Dieta/metabolismo , Medicamentos de Ervas Chinesas/metabolismo , Trato Gastrointestinal/enzimologia , Ração Animal/análise , Fenômenos Fisiológicos da Nutrição Animal/efeitos dos fármacos , Animais , Galinhas/crescimento & desenvolvimento , Galinhas/imunologia , Galinhas/metabolismo , Dieta/veterinária , Carboidratos da Dieta/administração & dosagem , Suplementos Nutricionais/análise , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas/administração & dosagem , Masculino , Distribuição Aleatória
2.
Cryo Letters ; 38(3): 194-201, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28767742

RESUMO

BACKGROUND: Basic fibroblast growth factor is a potent angiogenic factor. OBJECTIVE: To study the concentration and in vitro culture time of bFGF that maximize the angiogenesis for transplanted human ovarian tissues. MATERIALS AND METHODS: Vitrified and rewarmed human ovarian tissues were cultured in vitro with bFGF (0, 25, 50, 100, 150 and 200 ng/ml) for different periods (1 h, 2 d, 5 d and 7 d) before transplantation. The effect of bFGF on follicle survival was studied by evaluating the pregraft group, control group (no bFGF) and bFGF-treated group. CD34, Ki-67 and AC-3 immuno-histochemical (IHC) staining and histological analysis was used to evaluate angiogenesis, proliferration, apoptosis and follicular quantity. RESULTS: Treatments with 100 and 150 ng/ml bFGF improved the angiogenesis for grafted human ovarian tissues after in vitro culture for 2 days. The proliferation and survival of follicles were significantly increased. CONCLUSION: bFGF improved the quality of vitrified-warmed human ovarian tissues after transplantation.


Assuntos
Fator 2 de Crescimento de Fibroblastos/farmacologia , Neovascularização Patológica/tratamento farmacológico , Ovário/irrigação sanguínea , Ovário/transplante , Animais , Apoptose/efeitos dos fármacos , Feminino , Xenoenxertos , Humanos , Camundongos , Ovário/efeitos dos fármacos , Transplante Heterólogo , Vitrificação
3.
J Bone Joint Surg Br ; 94(7): 956-60, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22733953

RESUMO

This prospective multicentre study was undertaken to determine whether the timing of the post-operative administration of bisphosphonate affects fracture healing and the rate of complication following an intertrochanteric fracture. Between August 2008 and December 2009, 90 patients with an intertrochanteric fracture who underwent internal fixation were randomised to three groups according to the timing of the commencement of risedronate treatment after surgery: Group A (from one week after surgery), Group B (from one month after surgery), and Group C (from three months after surgery). The radiological time to fracture healing was assessed as the primary endpoint, and the incidence of complications, including excessive displacement or any complication requiring revision surgery, as the secondary endpoint. The mean time to fracture healing post-operatively in groups A, B and C was 10.7 weeks (SD 4.4), 12.9 weeks (SD 6.2) and 12.3 weeks (SD 7.1), respectively (p = 0.420). At 24 weeks after surgery, all fractures had united, except six that had a loss of fixation. Functional outcomes at one year after surgery according to the Koval classification (p = 0.948) and the incidence of complications (p = 0.386) were similar in the three groups. This study demonstrates that the timing of the post-operative administration of bisphosphonates does not appear to affect the rate of healing of an intertrochanteric fracture or the incidence of complications.


Assuntos
Conservadores da Densidade Óssea/administração & dosagem , Ácido Etidrônico/análogos & derivados , Consolidação da Fratura/efeitos dos fármacos , Fraturas do Quadril/cirurgia , Idoso , Idoso de 80 Anos ou mais , Conservadores da Densidade Óssea/farmacologia , Conservadores da Densidade Óssea/uso terapêutico , Esquema de Medicação , Ácido Etidrônico/administração & dosagem , Ácido Etidrônico/farmacologia , Ácido Etidrônico/uso terapêutico , Feminino , Fixação Interna de Fraturas/métodos , Humanos , Masculino , Pessoa de Meia-Idade , Osteoporose/tratamento farmacológico , Fraturas por Osteoporose/prevenção & controle , Fraturas por Osteoporose/cirurgia , Período Pós-Operatório , Estudos Prospectivos , Ácido Risedrônico , Prevenção Secundária
4.
Clin Radiol ; 66(7): 609-13, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21450282

RESUMO

AIM: To estimate the acceptable compression ratio of full-field digital mammography (FFDM) using the Joint Photographic Experts Group (JPEG) 2000 compression algorithm. MATERIALS AND METHODS: Eighty cases that included images of 40 masses (20 benign, 20 malignant) and 40 microcalcifications (20 benign, 20 malignant) were collected. The images were compressed to five different lossy ratios: 20:1, 40:1, 60:1, 80:1, and 100:1, and four radiologists independently determined whether the compressed group was distinguishable from the control group. The ratio of the compressed group that was rated indistinguishable from the control group was compared for each reviewer, and the results were analysed for agreements of three or more reviewers. RESULTS: The ability to distinguish the compressed image from the control group is given as a range across the four reviewers: 0-1.3% (0/80 to 1/80) of the 20:1, 0-2.5% (0/80 to 2/80) of the 40:1, 5-7.5% (4/80 to 6/80) of the 60:1, 10-37.5% (8/80 to 30/80) of the 80:1, and 30-87.5% (24/80 to 70/80) of the 100:1. For three compression groups (20:1, 40:1, and 60:1), three or more reviewers agreed that there was a distinguishable difference for 0/80, 0/80, and 3/80 images, respectively. Thus, the compressed images do not differ significantly from the control group (p>0.05). However, the 80:1 and 100:1 compressed images were different for 9/80 and 29/80 images, respectively, which is significantly different from the control group (p<0.05). CONCLUSION: The lossy 60:1 compression ratio for FFDM is visually identical to the control image and, therefore, potentially acceptable for primary interpretation.


Assuntos
Neoplasias da Mama/diagnóstico por imagem , Calcinose/diagnóstico por imagem , Compressão de Dados/métodos , Processamento de Imagem Assistida por Computador/métodos , Mamografia/métodos , Intensificação de Imagem Radiográfica/métodos , Adulto , Idoso , Algoritmos , Feminino , Humanos , Mamografia/instrumentação , Pessoa de Meia-Idade
5.
Comp Biochem Physiol B Biochem Mol Biol ; 149(4): 589-98, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18221905

RESUMO

The mud shrimp, Upogebia major is a gonochoristic species with distinct sexual dimorphism; however, the male has the "ovarian part of testis" in the gonad and mature-looking eggs appear in a similar reproductive cycle to the female. Vitellogenesis of U. major was investigated focusing on the characterization of vitellogenin (Vg) gene expression and Vg processing. Vg cDNA cloned by PCR-based methods was 7,799 bp-long, encoding 2,568 amino acids in a single open reading frame. The deduced amino acid sequence shared common characteristics conserved in other shrimp Vgs. The Vg gene was expressed in the hepatopancreas of females and males, the ovary, and the ovarian part of testis. Vitellins (Vns) were detected in the gonads of both females and males as three prominent polypeptides with apparent molecular masses of 82 kDa, 100 kDa, and 115 kDa. N-terminal amino acid sequences determined for the three polypeptides were present in the deduced amino acid sequence, demonstrating that they derived from a single long Vg polypeptide. Immunoblot analysis using polyclonal antibodies raised against two Vns (82 kDa and 100 kDa) confirmed Vg processing in the hepatopancreas, in the hemolymph and possibly in the oocytes, similarly in both sexes.


Assuntos
Decápodes/genética , Decápodes/metabolismo , Regulação da Expressão Gênica , Processamento de Proteína Pós-Traducional , Caracteres Sexuais , Vitelogênese/genética , Vitelogeninas/genética , Vitelogeninas/metabolismo , Sequência de Aminoácidos , Animais , Clonagem Molecular , DNA Complementar/genética , Decápodes/anatomia & histologia , Decápodes/citologia , Feminino , Hemolinfa/metabolismo , Hepatopâncreas/metabolismo , Masculino , Dados de Sequência Molecular , Oócitos/metabolismo , Vitelogeninas/química
6.
Comp Biochem Physiol B Biochem Mol Biol ; 148(4): 445-53, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17804271

RESUMO

We cloned and sequenced two vitellogenin (vg) cDNAs of the carp, Cyprinus carpio, using a cDNA library constructed from estradiol-17 beta (E2)-treated livers. One was a novel, longer 5000 bp-long cDNA termed vg-B2 encoding 1624 amino acids in a single open reading frame. The other was a shorter cDNA (vg-B1), identical to that registered previously as carp vg cDNA in the international nucleotide sequence database. The deduced amino acid sequences of these two molecules were well-aligned with known vertebrate Vgs sharing common characteristics such as N-terminal lipovitellin I (LVI), phosvitin (PV) and C-terminal lipovitellin II (LVII). The novel Vg-B2 bore a highly conserved GL/ICG motif within the LVII region, in contrast to the shorter Vg-B1 that has a truncated C-terminal and lacks the beta-component within the LVII region including the GL/ICG motif. Both vg-B2 and vg-B1 genes were expressed in the livers of females and E2-injected males. Western blot analysis using anti-Vg and anti-vitellin (Vn) antisera demonstrated that both Vg-B2 and Vg-B1 were detected as polypeptides with an estimated molecular mass of 180 kDa and 160 kDa, respectively, in the blood of females and E2-injected males. The results suggest the potential utilization of these genes as sensitive xenoestrogenic markers.


Assuntos
Carpas/genética , Carpas/metabolismo , Perfilação da Expressão Gênica , Vitelogeninas/genética , Vitelogeninas/metabolismo , Motivos de Aminoácidos , Animais , Biomarcadores , Clonagem Molecular , DNA Complementar/genética , Estradiol/metabolismo , Feminino , Hepatócitos/metabolismo , Masculino , Dados de Sequência Molecular , Filogenia , RNA , Caracteres Sexuais , Vitelogeninas/química
7.
J Comp Neurol ; 503(5): 627-41, 2007 Aug 10.
Artigo em Inglês | MEDLINE | ID: mdl-17559094

RESUMO

Phox2b is required for development of the peripheral autonomic nervous system and a subset of cranial nerves and lower brainstem nuclei. Phox2b mutations in man cause diffuse autonomic dysfunction and deficits in the automatic control of breathing. Here we study the distribution of Phox2b in the adult rat hindbrain to determine whether this protein is selectively expressed by neurons involved in respiratory and autonomic control. In the medulla oblongata, Phox2b-immunoreactive nuclei were present in the dorsal vagal complex, intermediate reticular nucleus, dorsomedial spinal trigeminal nucleus, nucleus ambiguus, catecholaminergic neurons, and retrotrapezoid nucleus (RTN). Phox2b was expressed by both central excitatory relays of the sympathetic baroreflex (nucleus of the solitary tract and C1 neurons) but not by the inhibitory relay of this reflex. Phox2b was absent from the ventral respiratory column (VRC) caudal to RTN and rare within the parabrachial nuclei. In the pons, Phox2b was confined to cholinergic efferent neurons (salivary, vestibulocochlear) and noncholinergic peritrigeminal neurons. Rostral to the pons, Phox2b was detected only in the oculomotor complex. In adult rats, Phox2b is neither a comprehensive nor a selective marker of hindbrain autonomic pathways. This marker identifies a subset of hindbrain neurons that control orofacial movements (dorsomedial spinal trigeminal nucleus, pontine peritrigeminal neurons), balance and auditory function (vestibulocochlear efferents), the eyes, and both divisions of the autonomic efferent system. Phox2b is virtually absent from the respiratory rhythm and pattern generator (VRC and dorsolateral pons) but is highly expressed by neurons involved in the chemical drive and reflex regulation of this oscillator.


Assuntos
Sistema Nervoso Central/metabolismo , Proteínas de Homeodomínio/metabolismo , Fatores de Transcrição/metabolismo , Animais , Animais Recém-Nascidos , Sistema Nervoso Central/anatomia & histologia , Colina O-Acetiltransferase/metabolismo , Regulação da Expressão Gênica no Desenvolvimento/fisiologia , Glutamato Descarboxilase/genética , Glutamato Descarboxilase/metabolismo , Isoenzimas/genética , Isoenzimas/metabolismo , Masculino , Neurônios Motores/metabolismo , Proteínas Proto-Oncogênicas c-fos/metabolismo , Ratos , Ratos Sprague-Dawley , Estilbamidinas/metabolismo , Tirosina 3-Mono-Oxigenase/metabolismo , Proteína Vesicular 2 de Transporte de Glutamato/genética , Proteína Vesicular 2 de Transporte de Glutamato/metabolismo
8.
Biochem Pharmacol ; 61(7): 787-93, 2001 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-11274963

RESUMO

The effect of camphor, a monoterpenoid, on catecholamine secretion was investigated in bovine adrenal chromaffin cells. Camphor inhibited [3H]norepinephrine ([3H]NE) secretion induced by a nicotinic acetylcholine receptor (nAChR) agonist, 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP), with a half-maximal inhibitory concentration (IC50) of 70 +/- 12 microM. In addition, camphor inhibited the rise in cytosolic calcium ([Ca2+]i) and sodium ([Na+]i) induced by DMPP with IC50 values of 88 +/- 32 and 19 +/- 2 microM, respectively, suggesting that the activity of nAChRs is also inhibited by camphor. On the other hand, binding of [3H]nicotine to nAChRs was not affected by camphor. [Ca2+]i increases induced by high K+, veratridine, and bradykinin were not affected by camphor. The data suggest that camphor specifically inhibits catecholamine secretion by blocking nAChRs without affecting agonist binding.


Assuntos
Cânfora/farmacologia , Células Cromafins/efeitos dos fármacos , Antagonistas Nicotínicos/farmacologia , Receptores Nicotínicos/metabolismo , Animais , Anti-Infecciosos Locais/farmacologia , Sítios de Ligação/efeitos dos fármacos , Cálcio/metabolismo , Catecolaminas/metabolismo , Bovinos , Células Cromafins/metabolismo , Iodeto de Dimetilfenilpiperazina/farmacologia , Interações Medicamentosas , Técnicas In Vitro , Nicotina/farmacologia , Agonistas Nicotínicos/farmacologia , Norepinefrina/metabolismo , Receptores Nicotínicos/efeitos dos fármacos , Sódio/metabolismo , Fatores de Tempo , Trítio
9.
Zhonghua Yi Xue Za Zhi (Taipei) ; 48(5): 404-7, 1991 Nov.
Artigo em Chinês | MEDLINE | ID: mdl-1659944

RESUMO

A 27 year-old woman had a normal full-term delivery 4 years after bone narrow transplantation for severe aplastic anemia. She had received combination regimens of systemic high-dose cyclophosphamide and one fraction of total body irradiation for 300cGy as pre-BMT conditioning regimens. This case illustrates that after regimens incorporating total body irradiation and high-dose cyclophosphamide, recovery of ovarian function and normal pregnancy are still possible.


Assuntos
Anemia Aplástica/cirurgia , Transplante de Medula Óssea , Gravidez/fisiologia , Adulto , Ciclofosfamida/efeitos adversos , Feminino , Humanos , Ovário/fisiologia , Radioterapia/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA